Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simbrinza as Adjunctive Therapy to PGA in Glaucoma or Ocular Hypertension
NCT02419508Phase 4Completed
- Sponsor
- Alcon Inc.
- Start
- Aug 2015
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of brinzolamide + brimonidine in open-angle glaucoma (OAG), ocular hypertension, sponsored by Alcon Inc.. Started Aug 2015; status: completed.
02
Drugs
brinzolamide + brimonidine
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT02419508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02419508.